跳至主要内容
临床试验/NCT05760482
NCT05760482已完成不适用

Evaluation of the Relationship Between Bruxism and Tryptophan Metabolites

Selcuk University2 个研究点 分布在 2 个国家目标入组 92 人开始时间: 2023年9月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
92
试验地点
2
主要终点
serum kynurenic acid level measurement

研究概览

简要总结

Psychological causes are often cited as the most important of the underlying factors for bruxism. However, there are very few studies that can objectively demonstrate this. There are studies that are generally based on subjective data, that is, on questionnaires that indicate anxiety or stress. Recent studies have shown that tryptophan and its metabolites are associated with psychological health. In this study, researchers will measure the serum values of metabolites in the tryptophan pathway. Also, researchers will observe whether these metabolite levels differ significantly in patients with and without bruxism.

详细描述

Bruxism is a common health problem that occurs throughout life and has a prevalence of 9% to 31% among adults. This common muscle disorder, characterized by teeth grinding or clamping, which can occur during sleep or day, is considered multifactorial with potential effects on the central nervous system. A possible relationship between mental health and bruxism has been investigated due to the indication of psychological factors such as anxiety and stress at the onset of bruxism. It has been reported that when the presence of mental disorders causes changes in the regulation of the central nervous system, they can act as a trigger point for bruxism.

Depression and anxiety disorders are the most common mental disorders studied and are expected to be the most common chronic condition by 2050. The emerging field of nutritional psychiatry offers some opportunities for clinical intervention for individuals suffering from depression and anxiety. L-tryptophan, a precursor of serotonin, is expected to contribute to the correction of depressive and anxious moods.

The primary catabolic pathway of tryptophan is the pathway of kynurenine, which is responsible for about 95-99% of tryptophan metabolism in the body. Tryptophan turns into kynurenine in the kynurenine pathway and is divided into two pathways. The first forms kynurenic acid, while the other forms 3-hydroxykynurenine (3-HK), 3-hydroxyanthranylic acid (3-HAA), and quinolinic acid (QA), respectively. The first pathway is considered neuroprotective, while the second pathway is known as neurotoxic.

In studies trying to explain the link between tryptophan and its metabolites and depression, they have emphasized that depression is caused by an imbalance in the kynurenine pathway and that the amount of quinolinic acid, which is neurotoxic, increases, while peripheral kynurenine, which is neuroprotective, decreases. It has been shown that the neurotoxic metabolites formed in the kynurenine itself and its pathway may be associated with depression and anxiety. There are researchers who think that changes in these parameters and their proportions to each other indicate different psychological states.

Changes in serum levels of these metabolites in cases of stress and anxiety have been supported by the studies mentioned above. Although most authorities assume that bruxism is based on psychological factors, the studies supporting them are usually anxiety and stress-focused survey studies based on subjective data. This assumption; researchers could not find a study comparing it with objective data. This study aims to present a possible relationship between bruxism and tryptophan metabolites in volunteer individuals with and without bruxism. The researchers' initial hypothesis is that "Changes in tryptophan and catabolites play a role in the etiology of bruxism."

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • age range 18-50
  • applying to our clinic with the complaint of bruxism
  • no psychological drug
  • no active orthodontic treatment
  • no musculoskeletal disease
  • no removable prosthesis
  • no obstructive sleep apnea syndrome
  • "Class I" according to RDC/TMD classification
  • "probable" according to bruxism classifiacation
  • accept to fill out the questionnaire
  • accept to give a blood sample
  • being volunteer
  • accept to sign the informed consent

排除标准

  • indicate to quit the study at anytime
  • not fully fill out the questionnaire
  • encountering any complication during taking a blood sample
  • can not take an adequate blood sample
  • presenting any below diseases;
  • acute myocardial infarction
  • pulmonary emboli
  • deep venous thrombosis
  • heart failure
  • cerebral edema
  • hypertensive encephalopathy
  • hypoglycemia
  • hepatic encephalopathy
  • fluid-electrolyte disturbances
  • acute-chronic renal failure

结局指标

主要结局

serum kynurenic acid level measurement

时间窗: blood sample will be taken 5 minutes after the patient sits the dental unit

serum kynurenic acid level measurement

serum quinolinic acid level measurement

时间窗: blood sample will be taken 5 minutes after the patient sits the dental unit

serum quinolinic acid level measurement

serum kynurenin level measurement

时间窗: blood sample will be taken 5 minutes after the patient sits the dental unit

serum kynurenin level measurement

serum tryptophane level measurement

时间窗: blood sample will be taken 5 minutes after the patient sits the dental unit

serum tryptophane level measurement

serum 3-hydroxyanthranilic level measurement

时间窗: blood sample will be taken 5 minutes after the patient sits the dental unit

serum 3-hydroxyanthranilic(3-HAA) level measurement

serum 3-hydroxykynurenin level measurement

时间窗: blood sample will be taken 5 minutes after the patient sits the dental unit

serum 3-hydroxykynurenin(3-HK) level measurement

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gokhan Gurses

Assistant Professor

Selcuk University

研究点 (2)

Loading locations...

相似试验